Stem Cell Therapy Market Demand, Size and Growth Rate Forecast 2035
According to Payal Rabde, who specializes in biotechnology, regenerative medicine, and healthcare market research, with 4+ years of experience in market research and industry analysis, the stem cell therapy market is on track for strong long-term expansion, growing from USD 768.72 million in 2026 to USD 5,835.53 million by 2035 at a 25.26% CAGR. Her research identifies allogeneic stem cell therapies and oncology applications as the leading market segments, while autologous therapies and musculoskeletal disorders present significant future opportunities. She highlights North America's market leadership, rapid growth across Asia-Pacific, and competitive developments led by companies including Abeona Therapeutics, Alloy Therapeutics, Astellas Pharma, Bluebird Bio, Caribou Biosciences, Novo Nordisk, and Takeda Pharmaceuticals Co. Ltd.
Last Updated : 11 August 2026
Category: Therapeutic Area
Insight Code: 5451
Format: PDF / PPT / Excel